La, Justin
Loeb, Charles A. http://orcid.org/0000-0002-4570-041X
Barham, David W.
Miller, Jake
Chung, Eric http://orcid.org/0000-0003-3373-3668
Gross, Martin S. http://orcid.org/0000-0002-2716-8642
Hatzichristodoulou, Georgios
Park, Sung Hun http://orcid.org/0000-0002-9548-062X
Perito, Paul E. http://orcid.org/0000-0002-4979-6308
Suarez-Sarmiento, Alfredo
Van Renterghem, Koenraad
Yafi, Faysal A.
Article History
Received: 19 January 2022
Revised: 25 July 2022
Accepted: 27 July 2022
First Online: 8 August 2022
Competing interests
: JL, CAL, DWB, JM, GH, SHP, and AS-S have no disclosures to report. EC has an honorarium with Coloplast. MSG is a consultant for Coloplast. PEP is a consultant for Coloplast, AMS, and Urofill. KVR is on the advisory board for Boston Scientific and a consultant for Coloplast. FAY is on the advisory board and is a consultant for Coloplast, a speaker for Antares Pharma, a speaker for Clarus Therapeutics, on the advisory board for Promescent, and a research investigator for Viome.
: This study was conducted in line with best practices and codes of conduct of each institution represented and was the study was approved by the Institutional Review Board.